Literature DB >> 27738564

Hospital-Acquired Methicillin-resistant Staphylococcus aureus Bacteremia Related to Medicare Antibiotic Prescriptions: A State-Level Analysis.

Bryce T Fukunaga1, Wesley K Sumida1, Deborah A Taira1, James W Davis1, Todd B Seto1.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) results in almost half of all deaths caused by antibiotic resistant organisms. Current evidence suggests that MRSA infections are associated with antibiotic use. This study examined state-level data to determine whether outpatient antibiotic use was associated with hospital-acquired MRSA (HA-MRSA) infections. The 2013 Centers for Disease Control and Prevention (CDC) Healthcare-Associated Infections Progress Report was used to obtain HA-MRSA infection rates. Data on the number of antibiotic prescriptions with activity towards methicillin-sensitive Staphylococcus aureus (MSSA) at the state level were obtained from the 2013 Medicare Provider Utilization and Payment Data: Part D Prescriber Public Use File. Pearson's correlation coefficient was used to analyze the relationship between the number of antibiotic prescriptions and HA-MRSA infection rates. The average number of HA-MRSA infections was 0.026 per 1000 persons with the highest rates concentrated in Southeastern and Northeastern states. The average number of outpatient prescriptions per capita was 0.74 with the highest rates in Southeastern states. A significant correlation (ρ = 0.64, P <.001) between infections and prescriptions was observed, even after adjusting for non-reporting hospitals. This association provides evidence of the importance of appropriate antibiotic prescribing. Prescriber and heat map data may be useful for targeting antimicrobial stewardship programs in an effort to manage appropriate antibiotic use to help stop antibiotic resistance.

Entities:  

Keywords:  Antibiotic resistance; Antimicrobial stewardship; Medicare; Methicillin-resistant Staphylococcus aureus; Methicillin-sensitive Staphylococcus aureus

Mesh:

Substances:

Year:  2016        PMID: 27738564      PMCID: PMC5056633     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  27 in total

1.  A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use.

Authors:  Mamoon A Aldeyab; Mary P Kearney; James C McElnay; Fidelma A Magee; Geraldine Conlon; Dianne Gill; Peter Davey; Arno Muller; Herman Goossens; Michael G Scott
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

Review 2.  Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis.

Authors:  Céire Costelloe; Chris Metcalfe; Andrew Lovering; David Mant; Alastair D Hay
Journal:  BMJ       Date:  2010-05-18

3.  Impact of antibiotic exposure patterns on selection of community-associated methicillin-resistant Staphylococcus aureus in hospital settings.

Authors:  Lidia Kardas-Sloma; Pierre Yves Boëlle; Lulla Opatowski; Christian Brun-Buisson; Didier Guillemot; Laura Temime
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

Review 4.  Epidemiology of staphylococcal resistance.

Authors:  Andrew F Shorr
Journal:  Clin Infect Dis       Date:  2007-09-15       Impact factor: 9.079

5.  Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship.

Authors:  Rebecca R Roberts; Bala Hota; Ibrar Ahmad; R Douglas Scott; Susan D Foster; Fauzia Abbasi; Shari Schabowski; Linda M Kampe; Ginevra G Ciavarella; Mark Supino; Jeremy Naples; Ralph Cordell; Stuart B Levy; Robert A Weinstein
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

6.  Trends in prescribing beta-lactam antibiotics for treatment of community-associated methicillin-resistant Staphylococcus aureus infections.

Authors:  Kalpana Gupta; Ann Macintyre; Gary Vanasse; Louise-Marie Dembry
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

7.  Effect of antibiotic prescribing in primary care on meticillin-resistant Staphylococcus aureus carriage in community-resident adults: a controlled observational study.

Authors:  Céire Costelloe; Andrew Lovering; Alan Montgomery; Deirdre Lewis; Cliodna McNulty; Alastair D Hay
Journal:  Int J Antimicrob Agents       Date:  2011-11-10       Impact factor: 5.283

Review 8.  Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development.

Authors:  Emily A Morell; Daniel M Balkin
Journal:  Yale J Biol Med       Date:  2010-12

9.  Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections.

Authors:  Marin L Schweizer; Eli N Perencevich; Michael R Eber; Xueya Cai; Michelle D Shardell; Nikolay Braykov; Ramanan Laxminarayan
Journal:  Antimicrob Resist Infect Control       Date:  2013-10-15       Impact factor: 4.887

10.  The Ethical Significance of Antimicrobial Resistance.

Authors:  Jasper Littmann; A M Viens
Journal:  Public Health Ethics       Date:  2015-09-30       Impact factor: 1.940

View more
  7 in total

1.  Impact of Decolonization Protocols and Recurrence in Pediatric MRSA Skin and Soft-Tissue Infections.

Authors:  Steven T Papastefan; Christie Buonpane; Guillermo Ares; Beshoy Benyamen; Irene Helenowski; Catherine J Hunter
Journal:  J Surg Res       Date:  2019-05-06       Impact factor: 2.192

2.  Antibacterial isoamphipathic oligomers highlight the importance of multimeric lipid aggregation for antibacterial potency.

Authors:  Joseph S Brown; Zeinab J Mohamed; Christine M Artim; Dana N Thornlow; Joseph F Hassler; Vincent P Rigoglioso; Susan Daniel; Christopher A Alabi
Journal:  Commun Biol       Date:  2018-12-07

3.  Engineered Living Materials Based on Adhesin-Mediated Trapping of Programmable Cells.

Authors:  Shuaiqi Guo; Emilien Dubuc; Yahav Rave; Mick Verhagen; Simone A E Twisk; Tim van der Hek; Guido J M Oerlemans; Maxime C M van den Oetelaar; Laura S van Hazendonk; Mariska Brüls; Bruno V Eijkens; Pim L Joostens; Sander R Keij; Weizhou Xing; Martijn Nijs; Jitske Stalpers; Manoj Sharma; Marieke Gerth; Roy J E A Boonen; Kees Verduin; Maarten Merkx; Ilja K Voets; Tom F A de Greef
Journal:  ACS Synth Biol       Date:  2020-03-03       Impact factor: 5.110

4.  Control of Healthcare-Associated Infections using Silver Nanoparticles in Radiology.

Authors:  Gyunheung Ahn; Sungchul Kim
Journal:  J Med Phys       Date:  2022-08-05

Review 5.  Human Skin Microbiome: Impact of Intrinsic and Extrinsic Factors on Skin Microbiota.

Authors:  Krzysztof Skowron; Justyna Bauza-Kaszewska; Zuzanna Kraszewska; Natalia Wiktorczyk-Kapischke; Katarzyna Grudlewska-Buda; Joanna Kwiecińska-Piróg; Ewa Wałecka-Zacharska; Laura Radtke; Eugenia Gospodarek-Komkowska
Journal:  Microorganisms       Date:  2021-03-05

Review 6.  Chitosan Nanoparticle-Based System: A New Insight into the Promising Controlled Release System for Lung Cancer Treatment.

Authors:  Cha Yee Kuen; Mas Jaffri Masarudin
Journal:  Molecules       Date:  2022-01-12       Impact factor: 4.411

7.  Incidence of Vancomycin-Resistant Staphylococcus aureus Strains among Patients with Urinary Tract Infections.

Authors:  Samy Selim; Osama Ahmed Faried; Mohammed S Almuhayawi; Fayez M Saleh; Mohamed Sharaf; Nihal El Nahhas; Mona Warrad
Journal:  Antibiotics (Basel)       Date:  2022-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.